These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 8479081

  • 21. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Shamsian Khoramabadi A, Rabbani H, Shokri F.
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [Abstract] [Full Text] [Related]

  • 22. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma.
    Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ.
    Am J Clin Pathol; 2001 Apr; 115(4):571-81. PubMed ID: 11293906
    [Abstract] [Full Text] [Related]

  • 23. Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma.
    Veillon DM, Nordberg ML, Glass J, Sattar T, Cotelingam JD.
    Am J Clin Pathol; 2001 Nov; 116(5):781-2. PubMed ID: 11710698
    [No Abstract] [Full Text] [Related]

  • 24. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J, Powles R, Singhal S, Iveson T, Treleaven J, Catovsky D.
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [Abstract] [Full Text] [Related]

  • 25. Rituximab reduces the number of peripheral blood B-cells in vitro mainly by effector cell-mediated mechanisms.
    Voso MT, Pantel G, Rutella S, Weis M, D'Alò F, Urbano R, Leone G, Haas R, Hohaus S.
    Haematologica; 2002 Sep; 87(9):918-25. PubMed ID: 12217803
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vitro immune response of human peripheral lymphocytes. VI. Distribution and characterization of precursors for PHA- and protein A-induced colony-forming B cells.
    Kuritani T, Kishimoto T, Muraguchi A, Yamamura Y.
    J Immunol; 1980 Dec; 125(6):2633-7. PubMed ID: 6968791
    [Abstract] [Full Text] [Related]

  • 33. The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.
    Rasul E, Salamon D, Nagy N, Leveau B, Banati F, Szenthe K, Koroknai A, Minarovits J, Klein G, Klein E.
    PLoS One; 2014 Dec; 9(8):e106008. PubMed ID: 25162594
    [Abstract] [Full Text] [Related]

  • 34. [Prolymphocytic leukemia associated with serum hypo IgA].
    Muraoka A, Ogura M, Miyamoto K, Hashiramoto M, Matsuda K, Suzuki K, Maeda M, Okada K, Chinzei T, Yamashiro K.
    Rinsho Ketsueki; 1989 Oct; 30(10):1843-7. PubMed ID: 2593251
    [Abstract] [Full Text] [Related]

  • 35. B-lineage prolymphocytic leukemia as a distinct clinicopathologic entity.
    Katayama I, Aiba M, Pechet L, Sullivan JL, Roberts P, Humphreys RE.
    Am J Pathol; 1980 May; 99(2):399-412. PubMed ID: 6929655
    [Abstract] [Full Text] [Related]

  • 36. Effects of lymph node stromal cells on the differentiation of a cell line established from an atypical prolymphocytic leukemia with phenotypes of both chronic lymphocytic and hairy cell leukemias.
    Takeuchi H, Amano Y, Katayama I.
    Leuk Lymphoma; 1994 May; 14 Suppl 1():49-56. PubMed ID: 7820053
    [Abstract] [Full Text] [Related]

  • 37. Specific cutaneous involvement in B-cell prolymphocytic leukaemia.
    Bachmeyer C, Hunault M, Bazarbachi A, Hamant N, Aractingi S, Le Tourneau A, Marie JP, Diebold J, Zittoun R.
    Br J Dermatol; 1996 May; 134(5):979-80. PubMed ID: 8736353
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vivo binding of mouse IgG via polyreactive surface IgM abrogates progressive lymphocytosis in prolymphocytic leukemia.
    Weston KM, Mulligan SP, Raison RL.
    Leuk Lymphoma; 1998 Apr; 29(3-4):361-73. PubMed ID: 9684933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.